Medtronic Plc [MDT] stock prices are up 0.63% to $89.78 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MDT shares have gain 0.88% over the last week, with a monthly amount glided 2.88%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medtronic Plc [NYSE: MDT] stock has seen the most recent analyst activity on June 30, 2025, when Wolfe Research upgraded its rating to a Peer Perform. Previously, Leerink Partners started tracking the stock with Outperform rating on June 16, 2025, and set its price target to $110. On March 04, 2025, upgrade upgraded it’s rating to Buy and revised its price target to $107 on the stock. RBC Capital Mkts upgraded its rating to a Outperform and increased its price target to $105 on October 10, 2024. Oppenheimer reiterated its recommendation of a Perform and raised its price target to $94 on August 21, 2024. UBS upgraded its rating to Neutral for this stock on August 15, 2024, and upped its price target to $90. In a note dated August 14, 2024, Stifel downgraded an Hold rating on this stock and revised its target price from $100 to $85.
The stock price of Medtronic Plc [MDT] has been fluctuating between $76.68 and $96.25 over the past year. Currently, Wall Street analysts expect the stock to reach $107.29 within the next 12 months. Medtronic Plc [NYSE: MDT] shares were valued at $89.78 at the most recent close of the market. An investor can expect a potential return of 19.5% based on the average MDT price forecast.
Analyzing the MDT fundamentals
The Medtronic Plc [NYSE:MDT] reported sales of 33.54B for trailing twelve months, representing a surge of 3.94%. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.1 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.59.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 89.23 points at the first support level, and at 88.67 for the second support level. However, for the 1st resistance point, the stock is sitting at 90.13, and for the 2nd resistance point, it is at 90.47.
Ratios To Look Out For
It’s worth pointing out that Medtronic Plc [NYSE:MDT]’s Current Ratio is 1.85. In addition, the Quick Ratio stands at 1.42 and the Cash Ratio stands at 0.17. Considering the valuation of this stock, the price to sales ratio is 3.43, the price to book ratio is 2.40 and price to earnings (TTM) ratio is 24.82.
Transactions by insiders
Recent insider trading involved Salmon Sean, Officer, that happened on Jun 06 ’25 when 18378.0 shares were purchased. EVP & Pres Neuroscience, Wall Brett A. completed a deal on Jan 24 ’25 to sell 12437.0 shares. Meanwhile, Officer Wall Brett A. bought 12437.0 shares on Jan 24 ’25.
